跳至主要内容
临床试验/CTRI/2024/02/062696
CTRI/2024/02/062696尚未招募4 期

To study Efficacy and safety of Add-on Intravenous Ketamine in Obsessive Compulsive Disorder : A Pilot Randomized Controlled Trial - NI

Aashi Srivastava0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients diagnosed with Obsessive Compulsive Disorder according to ICD-10 and having Y-BOCS score more than 16
  • Duration more than 6 months with one failed trial of either SSRI or Clomipramine
  • Patients who give their consent

排除标准

  • Patients who do not give their informed consent.
  • Patients with present diagnosis of cardiovascular disorders, glaucoma, raised intracranial pressure and history of head trauma
  • Pregnant and lactating females
  • Patients with current diagnosis of schizophrenia
  • Patients diagnosed with Mental Retardation
  • Patients having hypersensitivity to ketamine
  • Patients with diagnosis of severe depression

研究者

发起方
Aashi Srivastava

相似试验